Spectroscopy E-Books
Historically, ion-exchange chromatography and size-exclusion chromatography (SEC) have been the reference techniques for the physicochemical characterization of biopharmaceutical compounds. However, reversed-phase liquid chromatography is naturally more compatible with mass spectrometry detection. This article discusses new trends in the use of ion-exchange chromatography and SEC, as well as the power of using ultrahigh-pressure liquid chromatography (UHPLC) and advanced reversed-phase LC columns, including sub-2-µm wide-pore porous particles or core–shell particles, for biopharmaceutical characterization. Read more
.
Joseph P. Smith Named 2024 Emerging Leader in Molecular Spectroscopy by Spectroscopy Magazine
September 25th 2024Joseph P. Smith, Director of Process R&D Enabling Technologies at Merck has been awarded the 2024 Emerging Leader in Molecular Spectroscopy Award, recognizing his significant contributions to the advancement of molecular spectroscopy in the pharmaceutical industry.